Living Cell Technologies (ASX:LCT) Share Price and News - StockTrack

Market Cap (30-Oct) TBC	Close (30-Jun) $0.015 0 (0%)	Volume (30-Jun) 1,798,203	Shortsold (17-Dec) 60,100 (0.01%) (538th)
52w High $0.000	52w Low $0.000	P/E -	EPS -

	Subject
	LCT LCT Ann: Cleansing Notice
	1 (current) 2 3
	LCT LCT Ann: Proposed issue of securities - LCT
	LCT LCT Ann: LCT to Issue Compensation Options
	LCT LCT Ann: Update - Proposed issue of securities - LCT
	LCT LCT Ann: Extension of Rights Issue
	LCT LCT Ann: Appendix 2A- Issue of shares and Options
	LCT LCT Ann: Proposed issue of securities - LCT
	LCT LCT Ann: Cleansing Notice
	LCT LCT Ann: Results of General Meeting
	LCT LCT Ann: Chairman Presentation
	LCT LCT Ann: Chairman's Address to the General Meeting
	LCT LCT Ann: Non-Renounceable Rights Issue Opens
	LCT LCT Ann: Update - Proposed issue of securities - LCT
	LCT LCT Ann: Proposed issue of securities - LCT
	LCT LCT Ann: Prospectus- Rights Issue
	LCT LCT Ann: LCT- Rights Issue
	LCT LCT Ann: Results of Annual General Meeting
	LCT LCT Ann: CEO's presentation to AGM
	LCT LCT Ann: Chairman's Address to the 2021 Annual General Meeting
	LCT LCT Ann: LCT Receives New Zealand R&D Tax Credit
	LCT LCT Ann: LCT Advises Price Change for Rights Issue
	LCT LCT Ann: Quarterly Activity Report and Appendix 4C
	LCT LCT Ann: Notice of General Meeting/ Proxy Form
	LCT LCT Ann: LCT Signs MOU with NZeno, Secures Pig Cells for NTCELL Trial
	LCT LCT Ann: Application for quotation of securities - LCT
	LCT LCT Ann: Cleansing Notice
	LCT LCT Ann: Proposed issue of securities - LCT
	LCT LCT Ann: Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
	LCT LCT Ann: Trading Halt
	LCT LCT Ann: Pause in Trading
	LCT LCT Ann: Appendix 4G and Corporate Governance Statement
	LCT LCT Ann: Annual Report to shareholders
	LCT LCT Ann: 2021 Annual General Meeting
	LCT LCT Ann: Notification of cessation of securities - LCT
	LCT LCT Ann: Preliminary Final Report and 2021 Financial Statements
	LCT LCT Ann: Business Update
	LCT LCT Ann: Quarterly Activity Report and Appendix 4C
	LCT LCT Ann: Appendix 3Z - K Taylor
	LCT LCT Ann: LCT Interim CEO Appointed
	LCT LCT Ann: Response to ASX Price Query
	LCT LCT Ann: Change of Director's Interest Notice - K Taylor
	LCT LCT Ann: Notification of cessation of securities - LCT
	LCT LCT Ann: Business Update
	LCT LCT Ann: Quarterly Activity Report and Appendix 4C
	LCT LCT Ann: LCT exits peptide projects
	LCT LCT Ann: Half Yearly Report and Accounts
	LCT LCT Ann: Change in substantial holding
	LCT LCT Ann: Change in substantial holding
	LCT LCT Ann: Response to ASX Price Query
	LCT LCT Ann: Quarterly Activity Report and Appendix 4C

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
30-Oct	$0.01	1,712,816	0.00 (0.00%)
23-Oct	$0.01	1,715,045	0.00 (7.69%)
20-Oct	$0.01	1,426,065	0.00 (0.00%)
19-Oct	$0.01	7,473	0.00 (0.00%)
18-Oct	$0.01	625,000	+0.00 (8.33%)
17-Oct	$0.01	1,292,941	0.00 (7.69%)
16-Oct	$0.01	329,192	0.00 (7.14%)
13-Oct	$0.01	220,186	+0.00 (16.67%)
12-Oct	$0.01	1,662,073	0.00 (7.69%)
11-Oct	$0.01	1,252,294	0.00 (7.14%)
10-Oct	$0.01	3,246,085	+0.00 (7.69%)
09-Oct	$0.01	1,378,040	0.00 (7.14%)
06-Oct	$0.01	500,334	0.00 (0.00%)
05-Oct	$0.01	1,349,330	0.00 (6.67%)
04-Oct	$0.02	346,772	0.00 (0.00%)
3 up, 7 down, and 5 flat days

High $0.02	Low $0.02	Trades 21	Turnover $27,023	Volume 1,798,203
30 June 2023 at 2:47pm

High $0.02	Low $0.02	Trades 21	Turnover $27,023	Volume 1,798,203
30 June 2023 at 2:47pm

Living Cell Technologies Health Care

$0.015 (0%)

$0.015 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices